Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor. A new approach to biological response modifier therapy

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 1, 2002, Pages 95-106

  Sarkar, S ^a   Begum, Z ^a   Dutta, S ^a   Chaudhuri, S ^a   Chaudhuri, Swapna ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Brain tumor; Cellular immunity; Immuno modulation; Sheep red blood cells; T11TS

Indexed keywords

ANTIGEN T11TS; BIOLOGICAL RESPONSE MODIFIER; ETHYLNITROSOUREA; IMMUNOSTIMULATING AGENT; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINESIS; FLOW CYTOMETRY; IMMUNOPRECIPITATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ROSETTE FORMATION; SHEEP ERYTHROCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; ANTIGENS, CD58; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTINEOPLASTIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; BRAIN NEOPLASMS; ERYTHROCYTE MEMBRANE; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MALE; NEUTROPHILS; RATS; RECEPTORS, IMMUNOLOGIC; ROSETTE FORMATION; SHEEP; T-LYMPHOCYTES;

EID: 0036223235     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Post-irradiation necrosis of the temporal lobe presenting as a glioma
2. Immune defects observed in patients with primary malignant brain tumors
3. Biological response modifier therapies for patients with malignant gliomas
4. Sheep erythrocytes provide metabolic triggers for tumor phagocytosis in polymorphonuclear neutrophils: A possible mechanism of tumor inhibition in mice
5. Immunomodulation and "Ia" variability in Dendritic lymph cells: Radiobinding immunoassay versus immune response study
6. The cell surface molecule recognized by the erythrocyte receptor of T lymphocyte
7. The T-lymphocyte glycoprotein CD2 binds to cell surface ligand LFA-3
8. Primary structure of lymphocyte function associated antigen-3 (LFA-3): The ligand of the T lymphocyte CD2 glycoprotein
9. Serological cross-reactivity of T11 target structure and lymphocyte function associated-antigen3. Evidence for structural homology of the sheep and human ligands of CD2
10. Functional glycan-free adhesion domain of human cell surface receptor CD58: Design, production and NMR studies
11. A space-time structure dimention of human CD2 reveals the CD58 binding mode
12. Molecular dessection of the CD-2-CD58 counter-receptor interface identifies CD2 Try86 and CD58 Lys34 residues as the functional "hot spot"
13. Effects of co-stimulation by CD58 on human T-cell cytokine production: A selective cytokine pattern with induction of high IL-10 production
14. The lymphocyte function - Associated LFA-1, CD2 and LFA-3 molecules: Cell adhesion receptors of the immune system
15. Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats
16. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats
17. Chemical induction of tumors in the nervous system
18. Studies on glycopeptide released by trypsin from sheep erythrocytes
19. Protein measurement with the Folin-Phenol reagent
20. Surface ultrastructural changes of percoll separated splenic lymphocytes from syngeneic and allogenic mice with transplantable ascites fibrosarcoma tumor
21. Antitumor activity of L-Asparaginase from Cylindrocarpon obstutisporum MB10 and its effects on the immune system
22. Immunological insurgence during intracranial tumor development: Cellular immunity in astrocytoma patients
23. Facilitation of functional compartmentalization of bone marrow cells in leukemia mice by biological response modifiers: An immunotherapeutic approach
24. Role of terminal galactose residues in N-linked sugar chains of sheep erythrocyte membrane glycoproteins in rosette formation with T-lymphocytes
25. Short course single agent therapy with an LFA3-1 gG1 fusion protein prolongs primate cardiac allograft survival
26. A dimeric form of soluble recombinant sheep LFA-3 (CD58) inhibits human T-cell proliferation by generating regulatory T cells
27. The IL-2/ IL-2 receptor system: A current overview
28. Activation of human thyrnocytes via the 50 Kd T11 sheep erythrocytes binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations
29. Purified lymphocyte function associated antigen-3 (LFA-3) activates human thymocytes via the CD2 pathway
30. An alternative pathway of T-cell activation: A functional role for the 50 Kd T11 sheep erythrocyte receptor protein
31. Two pathways of T-cell activation
32. The alternative pathway of T-cell activation: Biology, pathophysiology and perspective for immunopharmacology
33. The ligand of the erythrocyte receptor of T-lymphocytes: Expression on white blood cells and possible involvement in T-cell activation
34. Alternative pathway activation of T-cell by binding of CD2 to its cell-surface ligand
35. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): Complementry cell interaction molecules involved in T-cell activation
36. The T11 (3) epitope of the CD2 molecule, sheep erythrocytes, and the alternative T-cell activation pathway
37. Human glioma derived interleukin-10 inhibits antitumor immune response s in vitro
38. Neville-Golden: Effect of the expression of transforming growth factor beta2 in primery human glioblastomas on immunosuppression and loss of immunosurveillance
39. Interaction of CD2 with its ligand LFA-3, in human T-cell proliferation
40. Purified lymphocyte function-associated antigen-3 and T11 target structure are active in CD2 mediated T-cell stimulation
41. Co-stimulation by purified intercellular adhesion molecule I and lymphocyte function-associated antigen3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T-cells
42. The structure and ligand interaction of CD2: Implication for T-cell function
43. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy
44. CD2 and regulation of T cell anergy
45. Modulation of the CD2 receptor and nondisruption of the CD2/ CD48 interaction is the principle action of CD2-mediated immunosuppression in the rat
46. Interaction of the IL-2 receptor with the src-family kinase p56 lck.: Identification of novel intermolecular association
47. Association of src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells
48. Contingent genetic regulatory effects in T lymphocytes activation
49. Transmission of signals from the T lymphocyte antigen receptor to the gene responsible for cell proliferation and immune function: The missing link
50. IL-2 unresponsiveness in anergic CD4+ T-cells is due to defective signaling through the common gamma-chain of the IL-2 receptor
51. Biology of the interleukin-2 receptor
52. Lymphocytes targetting of the central nervous system: A review of affarent and efferent CNS-immune pathways
53. Immunobiology of primary intracranial tumors. III. Demonstration of a qualitative lymphocyte abnormality in-patients with primary brain tumors
54. Role of interleukin-2 (IL-2) and IL-2R receptor expression in the proliferative defect observed in mitogen stimulated lymphocytes from patients with glioma
55. Simultaneous increased expression of E rosette receptor (CD2, T11) and T-cell growth factor receptors on human T-lymphocytes during activation
56. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein
57. LFA-3 co-stimulates cytokine secretion by cytotoxic T-lymphocytes by providing a TCR-independent activation signal
58. Induction of human cytotoxic T lymphocytes by artificial antigen presenting cells
59. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function
60. LFA-1, LFA-2 and LFA-3 antigens are involved in CTL-target conjugation
61. Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function associated antigen 3 (LFA-3)
62. Early and late E-rosette forming neutrophils in persistent lambliasis